| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7151 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
| filingDate |
1990-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1365fc004c1fb5fc14a7a2a36a6225e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7c745111806ddd0c6c5da394fd3200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99c0ac048147f895182cc04607a2903a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43bc9e349aed64aaaf7bf054c4b9bb15 |
| publicationDate |
2005-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0393438-B1 |
| titleOfInvention |
TNF-receptor, TNF-binding protein and DNA coding therefor |
| abstract |
DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein represents the soluble domain. The DNA sequences can be used for the preparation of recombinant DNA molecules for the preparation of TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical compositions for the treatment of indications in which an adverse effect of TNF occurs. The TNF receptor or fragments thereof, or suitable host organisms transformed with recombinant DNA molecules containing the DNA coding for the TNF receptor, or fragments or modifications thereof, can be used to test substances for their interaction with the TNF receptor and/or for their influence on the biological effect of TNF. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010010108-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722631-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7915225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119605-B2 |
| priorityDate |
1989-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |